John L. Klinck Jr.

CIK: 0001302674

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CDLX

Cardlytics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CDLX
Cardlytics, Inc.
May 20, 2026
Award(A)
Restricted Stock Units
Direct
2.2K shares-
CDLX
Cardlytics, Inc.
May 20, 2026
Exercise(M)
Direct
11K shares-
CDLX
Cardlytics, Inc.
May 20, 2026
Award(A)
Restricted Stock Units
Direct
11K shares-
CDLX
Cardlytics, Inc.
May 23, 2025
Exercise(M)
Direct
11K shares-
CDLX
Cardlytics, Inc.
May 20, 2025
Award(A)
Restricted Stock Units
Direct
11K shares-

		Type	Shares	Price		Ownership
May 20, 2026	CDLX Cardlytics, Inc.	Award(A) Restricted Stock Units	2,200	-	-	Direct
May 20, 2026	CDLX Cardlytics, Inc.	Exercise(M)	11,000	-	$0	Direct
May 20, 2026	CDLX Cardlytics, Inc.	Award(A) Restricted Stock Units	11,000	-	-	Direct
May 23, 2025	CDLX Cardlytics, Inc.	Exercise(M)	11,000	-	-	Direct
May 20, 2025	CDLX Cardlytics, Inc.	Award(A) Restricted Stock Units	11,000	-	-	Direct

1-5 of 5 transactions

About Klinck John L. Jr.

Klinck John L. Jr. (SEC CIK 0001302674) files insider reports with the SEC as Director of Cardlytics, Inc. (CDLX).

Signal8 holds 4 ownership filings by Klinck John L. Jr., all Form 4s, filed between May 20, 2025 and Aug 24, 2026. Those filings report 5 transactions, from May 20, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Klinck John L. Jr.'s filings is in ATLANTA, GA.

Recent filings by Klinck John L. Jr.

May 20, 2026: Grant or award of CDLX derivative securities (Form 4, code A).
May 20, 2026: Option exercise of CDLX shares (Form 4, code M).
May 20, 2026: Grant or award of CDLX derivative securities (Form 4, code A).
May 23, 2025: Option exercise of CDLX shares (Form 4, code M).
May 20, 2025: Grant or award of CDLX derivative securities (Form 4, code A).

Other insiders filing for Cardlytics, Inc. (CDLX)

Gupta Amit, Chief Executive Officer
Hornsey Liane, Director
Gupta Srishti A., Director
Francis Jonathan Edward, Director
Fernandez Andre J, Director
Hill Scott A, Director

How to read Form 4 transaction codes